Menstrual Suppression for Adolescents with Developmental Disabilities
Authors:
- R.F. SpitzerRSR.F. Spitzer
- L.M. AllenLAL.M. Allen
- M.P. OrnsteinMOM.P. Ornstein
- 1 June 2009
- journal article
- review article
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 22 (3) , 143-149
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Venous Thromboembolism, Myocardial Infarction, and Stroke Among Transdermal Contraceptive System UsersObstetrics & Gynecology, 2007
- Menstrual and Contraceptive Issues among Young Women with Developmental Delay: A Retrospective Review of Cases at the Hospital for Sick Children, TorontoJournal of Pediatric and Adolescent Gynecology, 2005
- Extended Use of Transdermal Norelgestromin/Ethinyl Estradiol: A Randomized TrialObstetrics & Gynecology, 2005
- Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girlsJournal of Adolescent Health, 2004
- The transdermal contraceptive systemAmerican Journal of Obstetrics and Gynecology, 2004
- Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptomsObstetrics & Gynecology, 1997
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Intrauterine devices and pelvic inflammatory disease: an international perspectiveThe Lancet, 1992
- Pre-optic and hypothalamic neurons accumulate [3H]medroxyprogesterone acetate in male cynomolgus monkeysLife Sciences, 1986
- Endometrial Morphology During Long-Term Use of Levonorgestrel-Releasing Intrauterine DevicesInternational Journal of Gynecological Pathology, 1986